Why Does Neuropathy Occur?
Peripheral neuropathy occurs when peripheral nerves are damaged by a wide range of metabolic, toxic, inflammatory, hereditary, and structural causes, with diabetes being the single most common etiology worldwide, accounting for over 50% of cases in Western populations. 1, 2
Primary Mechanisms of Nerve Damage
The underlying pathophysiology varies by cause but generally involves:
- Metabolic injury: Chronic hyperglycemia in diabetes causes direct nerve damage through multiple pathways including oxidative stress, microvascular insufficiency, and accumulation of toxic metabolites 3, 4
- Toxic damage: Direct neurotoxicity from medications (chemotherapy agents like cisplatin, paclitaxel, vincristine), alcohol, or other toxins damages nerve axons 1, 2
- Nutritional deficiencies: Vitamin B12 deficiency impairs myelin synthesis and nerve function 1, 5
- Autoimmune/inflammatory: Antibody-mediated or inflammatory attack on nerve components 1, 5, 6
- Compression/structural: Physical nerve entrapment or injury 7
- Hereditary: Genetic mutations affecting nerve structure or metabolism 2, 6
Most Common Causes to Consider
When evaluating why neuropathy develops, prioritize these etiologies:
- Diabetes mellitus - affects approximately 206 million people worldwide with neuropathy 2
- Alcohol toxicity 1, 5
- Neurotoxic medications - chemotherapy (cisplatin, paclitaxel, vincristine), amiodarone, HIV medications 1, 2
- Vitamin B12 deficiency 1, 5
- Monoclonal gammopathies (multiple myeloma, MGUS) 1, 5
- Hypothyroidism 1, 5
- Renal disease 1, 5
- Infections (HIV, hepatitis C) 1, 5
- Autoimmune conditions (chronic inflammatory demyelinating polyneuropathy, vasculitis, systemic sclerosis, Sjögren's syndrome) 1, 6
- Hereditary neuropathies (Charcot-Marie-Tooth disease) 2, 6
Diabetic Neuropathy - The Leading Cause
In diabetic neuropathy specifically, poor glycemic control is the primary driver of nerve damage. 3, 4 The mechanisms include:
- Hyperglycemia-induced oxidative stress
- Microvascular damage reducing nerve blood flow
- Accumulation of advanced glycation end products
- Metabolic flux and glucose variability contributing to pain symptoms 8
Tight glycemic control can effectively prevent diabetic peripheral neuropathy and cardiac autonomic neuropathy in type 1 diabetes and modestly slow progression in type 2 diabetes, though it does not reverse established neuronal loss. 1, 4
Important Clinical Patterns
The pattern of nerve involvement provides clues to etiology:
- Length-dependent, symmetric distal sensory neuropathy (stocking-glove distribution) - suggests metabolic causes like diabetes, toxic exposures, or nutritional deficiencies 2, 9
- Asymmetric or focal patterns - consider compression, vasculitis, or other focal processes 1, 8
- Acute onset with rapid glycemic change - "insulin neuritis" or treatment-induced neuropathy of diabetes (typically resolves within one year) 8
- Small fiber predominance (pain, burning, temperature loss) - early diabetic neuropathy, amyloidosis 1
- Large fiber predominance (vibration loss, proprioception loss) - B12 deficiency, some hereditary neuropathies 1
Critical Pitfall
Up to 27% of adults with neuropathy have no identifiable cause after comprehensive testing (idiopathic neuropathy). 2 However, this diagnosis should only be made after excluding treatable causes through appropriate evaluation including glucose testing, vitamin B12 with metabolites, and serum protein electrophoresis with immunofixation 2, 9.
Tissue Deposit Diseases
Accumulation of abnormal proteins or substances causes widespread neuropathy in:
- Amyloidosis (AL, ATTR)
- Sarcoidosis
- Lewy body disorders
These conditions lead to infiltration and destruction of nerve tissue 6.
Why Chemotherapy Causes Neuropathy
Chemotherapy-induced peripheral neuropathy occurs through direct neurotoxic effects on nerve axons, with different agents having distinct patterns:
- Platinum compounds (cisplatin, oxaliplatin) - cause DNA damage in dorsal root ganglia
- Taxanes (paclitaxel) - disrupt microtubule function
- Vinca alkaloids (vincristine) - interfere with axonal transport 10, 11, 2
The severity correlates with cumulative dose, and symptoms may worsen for 2-3 months after stopping oxaliplatin (coasting phenomenon) 10.